Rote William E.: insider trades.
Rote William E. reported 11 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($13.1M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- ROTE WILLIAM E.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Officer · Chief Research Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Travere Therapeutics, Inc. | M | 350 | $17.96 | 98,547 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 55,000 | $15.46 | 153,547 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 57,500 | $26.88 | 211,047 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 65,104 | $63.12 | 145,943 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 47,746 | $63.61 | 98,197 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 63,907 | $61.99 | 130,488 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 29,021 | $62.66 | 101,467 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 3,000 | $63.65 | 98,467 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 270 | $65.31 | 98,197 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 39,000 | $25.25 | 154,745 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 39,650 | $17.96 | 194,395 | Form 4 |
Questions
What stock did Rote William E. buy or sell?
Rote William E. reported 11 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($13.1M), across 1 company.
Is Rote William E. the same person as other filers with this name?
This page covers SEC CIK 1698262 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/rote-william-e-1698262.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.